Mary A. Davis

5.0k total citations
89 papers, 3.9k citations indexed

About

Mary A. Davis is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mary A. Davis has authored 89 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 37 papers in Oncology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mary A. Davis's work include DNA Repair Mechanisms (18 papers), Cancer-related Molecular Pathways (16 papers) and Effects of Radiation Exposure (10 papers). Mary A. Davis is often cited by papers focused on DNA Repair Mechanisms (18 papers), Cancer-related Molecular Pathways (16 papers) and Effects of Radiation Exposure (10 papers). Mary A. Davis collaborates with scholars based in United States, Canada and China. Mary A. Davis's co-authors include Theodore S. Lawrence, Jonathan Maybaum, Mark S. Soloway, H. Hatanaka, Meredith A. Morgan, Leslie A. Parsels, Lili Zhao, Daniel P. Normolle, Alan D. Cherrington and William D. Ensminger and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Mary A. Davis

89 papers receiving 3.8k citations

Peers

Mary A. Davis

ONCOL

PRM

RNMI

IMMUN

Martin Pruschy Switzerland

L. Milas United States

Ting Xu China

Desiree Ehleiter United States

Uma Shankavaram United States

Zahid N. Rabbani United States

Eliot M. Rosen United States

Jason L. Parsons United Kingdom

Anna Dubrovska Germany

Christina M. Annunziata United States

Martin Pruschy Switzerland

Mary A. Davis

2.3k ×1.2

1.2k ×0.7

ONCOL

691 ×1.0

PRM

544 ×0.8

RNMI

669 ×1.1

IMMUN

Citations per year, relative to Mary A. Davis Mary A. Davis (= 1×) peers Martin Pruschy

Countries citing papers authored by Mary A. Davis

Since Specialization

Citations

This map shows the geographic impact of Mary A. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary A. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary A. Davis more than expected).

Fields of papers citing papers by Mary A. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary A. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary A. Davis. The network helps show where Mary A. Davis may publish in the future.

Co-authorship network of co-authors of Mary A. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Mary A. Davis. A scholar is included among the top collaborators of Mary A. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary A. Davis. Mary A. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wahl, Daniel, Joseph Dresser, Kari Wilder-Romans, et al.. (2016). Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis. Cancer Research. 77(4). 960–970. 67 indexed citations

Karnak, David, Carl G. Engelke, Leslie A. Parsels, et al.. (2014). Combined Inhibition of Wee1 and PARP1/2 for Radiosensitization in Pancreatic Cancer. Clinical Cancer Research. 20(19). 5085–5096. 125 indexed citations

Wei, Dongping, Leslie A. Parsels, David Karnak, et al.. (2013). Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair. Clinical Cancer Research. 19(16). 4422–4432. 80 indexed citations

Engelke, Carl G., Leslie A. Parsels, Yushen Qian, et al.. (2013). Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776. Clinical Cancer Research. 19(16). 4412–4421. 89 indexed citations

Yang, Jie, Donna McEachern, Wenyan Li, et al.. (2011). Radiosensitization of Head and Neck Squamous Cell Carcinoma by a SMAC-Mimetic Compound, SM-164, Requires Activation of Caspases. Molecular Cancer Therapeutics. 10(4). 658–669. 43 indexed citations

Cai, Xu‐Wei, Kerby Shedden, Mary A. Davis, et al.. (2011). Baseline Plasma Proteomic Analysis to Identify Biomarkers that Predict Radiation-Induced Lung Toxicity in Patients Receiving Radiation for Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(6). 1073–1078. 29 indexed citations

Morgan, Meredith A., Leslie A. Parsels, Lili Zhao, et al.. (2010). Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2 Checkpoint and Inhibition of Homologous Recombinational DNA Repair. Cancer Research. 70(12). 4972–4981. 249 indexed citations

Cai, Xu‐Wei, Kerby Shedden, Xiaoping Ao, et al.. (2010). Plasma Proteomic Analysis May Identify New Markers for Radiation-Induced Lung Toxicity in Patients With Non–Small-Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 77(3). 867–876. 31 indexed citations

Ahsan, Aarif, Susan M. Hiniker, Mary A. Davis, Theodore S. Lawrence, & Mukesh K. Nyati. (2009). Role of Cell Cycle in Epidermal Growth Factor Receptor Inhibitor-Mediated Radiosensitization. Cancer Research. 69(12). 5108–5114. 45 indexed citations

10.

Dai, Yao, Wenhua Tang, Jeffrey DeSano, et al.. (2008). Molecularly Targeted Radiosensitization of Human Prostate Cancer by Modulating Inhibitor of Apoptosis. Clinical Cancer Research. 14(23). 7701–7710. 50 indexed citations

11.

Morgan, Meredith A., et al.. (2008). Radiotherapy Combined with Gemcitabine and Oxaliplatin in Pancreatic Cancer Cells. Translational Oncology. 1(1). 36–43. 22 indexed citations

12.

Feng, Felix Y., Carlos López, Daniel P. Normolle, et al.. (2007). Effect of Epidermal Growth Factor Receptor Inhibitor Class in the Treatment of Head and Neck Cancer with Concurrent Radiochemotherapy In vivo. Clinical Cancer Research. 13(8). 2512–2518. 41 indexed citations

13.

Nyati, Mukesh K., Felix Y. Feng, Sooryanarayana Varambally, et al.. (2006). Ataxia Telangiectasia Mutated Down-regulates Phospho-Extracellular Signal-Regulated Kinase 1/2 via Activation of MKP-1 in Response to Radiation. Cancer Research. 66(24). 11554–11559. 25 indexed citations

14.

Chun, Patrick, et al.. (2006). Synergistic Effects of Gemcitabine and Gefitinib in the Treatment of Head and Neck Carcinoma. Cancer Research. 66(2). 981–988. 67 indexed citations

15.

Nyati, Mukesh K., et al.. (2004). Modulation of extracellular receptor kinase (ERK) by radiation. Cancer Research. 64. 297–297. 1 indexed citations

16.

Davis, Mary A., et al.. (2000). Interaction between gemcitabine and mitomycin-C in vitro. Cancer Chemotherapy and Pharmacology. 45(1). 38–42. 17 indexed citations

17.

Lawrence, Theodore S., Mary A. Davis, & Jonathan Maybaum. (1994). Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effects. International Journal of Radiation Oncology*Biology*Physics. 29(3). 519–523. 60 indexed citations

18.

Lawrence, Theodore S., Daniel P. Normolle, Mary A. Davis, & Jonathan Maybaum. (1993). The use of biphasic linear ramped pulsed field gel electrophoresis to quantify dna damage based on fragment size distribution. International Journal of Radiation Oncology*Biology*Physics. 27(3). 659–663. 20 indexed citations

19.

Lawrence, Theodore S., Mary A. Davis, Jonathan Maybaum, Philip L. Stetson, & William D. Ensminger. (1992). Modulation of iododeoxyuridine-mediated radiosensitization by 5-fluorouracil in human colon cancer cells. International Journal of Radiation Oncology*Biology*Physics. 22(3). 499–503. 11 indexed citations

20.

Davis, Mary A., et al.. (1991). Induction of megabase DNA fragments by 5-fluorodeoxyuridine in human colorectal tumor (HT29) cells.. Molecular Pharmacology. 39(3). 285–289. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact